We are evaluating the safety and early effectiveness of BNT116, both alone and with other treatments, for patients with advanced non-small cell lung cancer. This study aims to find better options for managing this condition.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced non-small cell lung cancer (NSCLC) is a type of lung cancer that has spread beyond the lungs to other parts of the body, often leading to serious health issues. It is characterized by symptoms such as persistent cough, chest pain, shortness of breath, and weight loss.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
